The Impact of Using Nanotechnology in the Early Detection and Diagnosis of Deadly Viral Diseases
Main Article Content
Abstract
Viral diseases are a common health problem with respect to their ability to be transmitted from one sitting to another, mutation, and possible wide outbreaks. Nanotechnology henceforth has come into the spotlight over the past decade in particular. Nanomaterials greatly improve the sensitivity, specificity, and speed of viral detection due to their unique physicochemical properties such as large surface area, tunable optical and electrical characteristics, and capacity for surface functionalization. In this research, we will be concentrating on different nanotechnology-based platforms such as AuNPs, QDs, CNTs, and nanopore sensors that can be employed in early viral diagnosis. A systematic review and a comparative analysis were carried out based on data from recent peer-reviewed journals, clinical reports, and case studies. The key focus was on nanomaterial integration with molecular recognition agents, including antibodies, aptamers, and CRISPR-based detection systems. Important diagnostic parameters, such as LOD (Limit of Detection), time response, clinical applicability, sensitivity, and so on were studied and compared. The outcomes showed that nanotechnology-based diagnostic platforms provide limits of detection well below traditional assays, such as ELISA and RT-PCR. For instance, gold nanoparticle-based colorimetric assays and QD-based immunoassays can detect virus concentrations at the femtomolar level in a matter of minutes. Plus, the CNT-graphene-based FET biosensors were very selective and had very little cross-reactivity for viral RNA detection. CRISPR-Cas systems, in combination with nanoparticle tags, allowed the most specific multiplexed detection on a single-nucleotide resolution level. These developments have facilitated the clinical validation of several nano-based diagnostic kits, especially during the COVID. Nanotechnologies applied to viral diagnostics present an alternative to conventional infectious disease management. Nanomaterials have excellent sensing capabilities, allowing the detection of viral markers in low abundance, which occur at the earliest stages of infection, thus enabling time interventions to halt viral spread. Still, a few challenges need to be addressed: standardization, reproducible large-scale manufacturing, regulatory approval, and ensuring the long-term biocompatibility and stability of the nanodevices. These challenges will be overcome through multidisciplinary collaboration and a sustained effort in innovating and developing nano-bio interface technologies. With this advantage procured by nanotechnology, viral diagnostic analysis methods can be ushered in as the ultra-sensitive and rapid detection mechanism at low cost. Nano-enabled detection technologies could be of utmost importance in outbreak preparedness and health response, chiefly in low-resource settings. Good research work and clinical evaluations will be required to ensure the validity of deployment of virus detection and control solutions from lab breakthroughs.